Literature DB >> 19362343

Value of frozen section analysis of enlarged lymph nodes during radical nephrectomy for renal cell carcinoma.

Xia Ming1, Lin Ningshu, Li Hanzhong, Huang Zhongming, Liu Tonghua.   

Abstract

OBJECTIVES: To avoid unnecessary lymphadenectomy for renal cell cancer (RCC) in patients with retroperitoneal enlarged lymph nodes (ELNs).
METHODS: Frozen section examination (FSE) of ELNs was used to evaluate the lymphatic status. In the present study, 114 patients with RCC underwent FSE of ELNs and concurrent regional lymphadenectomy. The results of FSE were compared with the final histopathologic results of lymphadenectomy. Some clinical tumor characteristics were also considered to improve the evaluation effect of the FSE. Multiple regression analysis was applied to define the independent risk factors for lymphatic metastasis.
RESULTS: The final histopathologic results indicated that 36 patients (31.6%) had nodal metastases. In these 36 patients, the FSE of ELNs revealed positive findings in 32 patients and negative findings in 4 patients. The sensitivity, specificity, concordance, and false-negative rate of FSE was 88.9%, 100%, 96.5%, and 11.1%, respectively. Multivariate analysis revealed that distant metastasis and high T stage (T3-T4) were independent risk factors for lymphatic metastasis. When FSE indicated negative results, no nodal metastases were found (64 patients) without these 2 risk factors.
CONCLUSIONS: ELNs in patients with RCC do not necessarily indicate metastatic disease, and more than one half of ELNs were benign. FSE of ELNs can be used to evaluate the lymphatic status. Using the findings from FSE and the clinical characteristics of the primary tumor, we can avoid unnecessary lymphadenectomy in patients with retroperitoneal ELNs.

Entities:  

Mesh:

Year:  2009        PMID: 19362343     DOI: 10.1016/j.urology.2008.12.075

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

1.  The impact of delaying radical nephrectomy for stage II or higher renal cell carcinoma.

Authors:  Kwang Hyun Kim; Dalsan You; In Gab Jeong; Cheryn Song; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim
Journal:  J Cancer Res Clin Oncol       Date:  2012-05-01       Impact factor: 4.553

Review 2.  The role of lymph node dissection in renal cell carcinoma.

Authors:  Brian F Chapin; Scott E Delacroix; Christopher G Wood
Journal:  Int J Clin Oncol       Date:  2011-04-28       Impact factor: 3.402

Review 3.  The Role of Lymph Node Dissection for Non-Metastatic Renal Cell Carcinoma: An Updated Systematic Review and Meta-Analysis.

Authors:  Xu Shi; Dechao Feng; Dengxiong Li; Facai Zhang; Wuran Wei
Journal:  Front Oncol       Date:  2022-01-12       Impact factor: 6.244

Review 4.  The rationale and the role of lymph node dissection in renal cell carcinoma.

Authors:  Umberto Capitanio; Bradley C Leibovich
Journal:  World J Urol       Date:  2016-06-30       Impact factor: 4.226

5.  Predictive and prognostic effect of inflammatory lymphadenopathies in renal cell carcinoma.

Authors:  Fabio Muttin; Angela Pecoraro; Alessandro Larcher; Paolo Dell'Oglio; Alessandro Nini; Francesco Cianflone; Francesco Trevisani; Federico Dehò; Alberto Briganti; Andrea Salonia; Francesco Montorsi; Roberto Bertini; Umberto Capitanio
Journal:  World J Urol       Date:  2018-07-25       Impact factor: 4.226

6.  The current role of lymph node dissection in the management of renal cell carcinoma.

Authors:  Joseph Edmund Jamal; Thomas William Jarrett
Journal:  Int J Surg Oncol       Date:  2011-06-07

7.  Diagnostic and Prognostic Significance of Radiologic Node-positive Renal Cell Carcinoma in the Absence of Distant Metastases: A Retrospective Analysis of Patients Undergoing Nephrectomy and Lymph Node Dissection.

Authors:  Hye Won Lee; Hwang Gyun Jeon; Byong Chang Jeong; Seong Il Seo; Seong Soo Jeon; Han Yong Choi; Hyun Moo Lee
Journal:  J Korean Med Sci       Date:  2015-08-13       Impact factor: 2.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.